Reemergence of PML in Natalizumab-Treated Patients - New Cases, Same Concerns

被引:68
作者
Major, Eugene O. [1 ]
机构
[1] NINDS, Lab Mol Med & Neurosci, Bethesda, MD 20892 USA
关键词
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; ANTIBODY NATALIZUMAB; CELLS;
D O I
10.1056/NEJMp0906248
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1041 / 1043
页数:3
相关论文
共 42 条
[41]   Early reduction of the splicing factor2/alternative splicing factor: a cellular inhibitor of the JC polyomavirus in natalizumab-treated MS patients long before developing progressive multifocal leukoencephalopathy [J].
Piu, Claudia ;
Ibba, Gabriele ;
Bertoli, Diego ;
Capra, Ruggero ;
Uleri, Elena ;
Serra, Caterina ;
Imberti, Luisa ;
Dolei, Antonina .
JOURNAL OF NEUROVIROLOGY, 2020, 26 (01) :133-137
[42]   Reduced expression of L-selectin in T-cells correlates with relative lymphocyte increase in patients with RRMS treated with natalizumab-functional implication towards PML risk [J].
Boziki, Marina Kleopatra ;
Karapanayotides, Theodoros ;
Papadopoulos, Georgios ;
Lagoudaki, Roza ;
Melo, Pamela ;
Bakirtzis, Christos ;
Nikolaidis, Ioannis ;
Gounari, Evdoxia ;
Tsavdaridou, Vasiliki ;
Skoura, Lemonia ;
Afrantou, Theodora ;
Tatsi, Theano ;
Grigoriadou, Eleni ;
Polyzoidou, Eleni ;
Mandoras, Nikolaos ;
Giantzi, Virginia ;
Kalogera - Fountzila, Anna ;
Ioannidis, Panagiotis ;
Parissis, Dimitrios ;
Pelidou, Sygkliti-Henrietta ;
Zoidou, Sofia ;
Grigoriadis, Nikolaos .
NEUROLOGICAL RESEARCH, 2020, 42 (03) :209-221